People · Operator
Named in public records as an officer, director or promoter · active 2009–2018 · Pharmaceuticals, Other Technology, Other, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Bellerophon Therapeutics, Inc. | — | Pharmaceuticals | Series B | $25.0M | $796.9M | 2017 |
| eCare Vault, Inc. | — | Other Technology | Seed | $4.6M | $91.8M | 2016 |
| Gemesis Corp | — | Other | Seed | $2.8M | $52.6M | 2009 |
| Fresenius Medical Care Renal Therapeutics, LLC | — | Other Health Care | Seed | $1.1M | $26.6M | 2010 |
Parag Shah at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Parag Shah on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Joseph Ruma | 1 | 47 |
| ADAM WEINSTEIN | 1 | 11 |
| ANDRE MOURA | 1 | 6 |
| Daniel Tasse | 1 | 4 |
| Jonathan M Peacock | 1 | 4 |
| Andre V. Moura | 1 | 3 |
| Gene Josephs | 1 | 2 |
| Yash Shah | 1 | 2 |
| Larry Pollock | 1 | 2 |
| JONATHAN PEACOCK | 1 | 2 |
| Adam B. Weinstein | 1 | 1 |
| Mary Ann P. Cloyd | 1 | 1 |
| Jens P. Luehring | 1 | 1 |
| Martin A. Dekker | 1 | 1 |
| Parag A. Shah | 1 | 1 |
| Peter B. Fernandes | 1 | 1 |
| Scott P. Bruder | 1 | 1 |
| Amy A. Edmonds | 1 | 1 |
| Deborah A. Quinn | 1 | 1 |
| Aparna Rao | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.